ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 42 filers reported holding ADC THERAPEUTICS SA in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,612,000 | -39.4% | 334,384 | 0.0% | 0.38% | -48.2% |
| Q2 2022 | $2,658,000 | -45.9% | 334,384 | 0.0% | 0.74% | -44.0% |
| Q1 2022 | $4,912,000 | -27.9% | 334,384 | -0.9% | 1.32% | +6.1% |
| Q4 2021 | $6,815,000 | -27.2% | 337,396 | -2.1% | 1.24% | -14.4% |
| Q3 2021 | $9,357,000 | +76.2% | 344,519 | +58.0% | 1.45% | +66.4% |
| Q2 2021 | $5,309,000 | -0.2% | 218,027 | 0.0% | 0.87% | +30.3% |
| Q1 2021 | $5,322,000 | -84.6% | 218,027 | -79.8% | 0.67% | -77.6% |
| Q4 2020 | $34,548,000 | +94.1% | 1,079,296 | +100.0% | 2.98% | -30.4% |
| Q3 2020 | $17,803,000 | -29.5% | 539,648 | 0.0% | 4.29% | -36.1% |
| Q2 2020 | $25,261,000 | – | 539,648 | – | 6.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $24,681,000 | 9.63% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $22,288,000 | 4.35% |
| Redmile Group, LLC | 7,432,429 | $109,182,000 | 3.41% |
| MPM BioImpact LLC | 334,384 | $4,912,000 | 1.32% |
| Indie Asset Partners, LLC | 96,572 | $1,419,000 | 1.07% |
| Eventide Asset Management | 1,975,000 | $29,013,000 | 0.46% |
| HHLR ADVISORS, LTD. | 500,000 | $7,345,000 | 0.15% |
| Virtus ETF Advisers LLC | 19,193 | $282,000 | 0.13% |
| Walleye Capital LLC | 248,354 | $3,648,000 | 0.10% |
| Matrix Capital Management Company, LP | 400,000 | $5,876,000 | 0.07% |